March 02 2017 - In her article 'Taking Aim At The Phoenix Of Cancer', Dr. Sandra Dunn describes her passion for research, what motivates her and how the PhoenixMD approach of tackling the molecular target RSK will lead to a durable treatment for Triple Negative Breast Cancer.
Read the article here